XTLB Insider Trading Activity and SEC Form 4 Filings
XTLB insider trading summary
No open-market insider purchases or sales of Xtl Biopharmaceuticals Ltd (XTLB) have been reported on SEC Form 4 in the past 12 months.
Latest XTLB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 19, 2008 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $1.5M (9,600,000 @ $0.15) |
| Nov 19, 2008 | Perceptive Advisors LLC | 10% Owner | Sell | $1.5M (9,600,000 @ $0.15) |
| Nov 19, 2008 | Joseph Edelman | 10% Owner | Sell | $1.5M (9,600,000 @ $0.15) |
| Nov 18, 2008 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $3.5M (24,681,360 @ $0.14) |
| Nov 18, 2008 | Joseph Edelman | 10% Owner | Sell | $3.5M (24,681,360 @ $0.14) |
| Nov 18, 2008 | Perceptive Advisors LLC | 10% Owner | Sell | $412K (2,696,450 @ $0.15) |
| Nov 18, 2008 | Perceptive Advisors LLC | 10% Owner | Sell | $3.5M (24,681,360 @ $0.14) |
| Nov 18, 2008 | Joseph Edelman | 10% Owner | Sell | $412K (2,696,450 @ $0.15) |
| Nov 18, 2008 | Joseph Edelman | 10% Owner | Sell | $5K (29,740 @ $0.16) |
| Nov 18, 2008 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $412K (2,696,450 @ $0.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.